Vaccine manufacturing is challenged by stringent global regulations, essential for ensuring safety and efficacy, with ...

What if the brain's response to stress could be read not in fleeting neurotransmitter bursts, but in the quieting of genes deep inside chromatin? Researchers at the University of Alabama at Birmingham ...

The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients by boosting their immune systems to help fight tumors. Research reported recently in the journal Nature ...

The health impact of a Covid infection was higher than the risks from the vaccine for teens and children - but it won't ...

Would it be flip of me to say, “A whole bunch of stuff?” It’s one of the main reasons I was attracted to the practice in the ...

At a margin of 40%, Palantir delivered $476 million net income (GAAP). Overall, the company now has $6.4 billion in cash and cash equivalents. More importantly for investors, Palantir raised its FY ...

Moderna (MRNA) just began dosing patients in a Phase 1/2 study of mRNA-2808, its experimental T-cell therapy for advanced multiple myeloma. This effort highlights Moderna's growing emphasis on cancer ...

AppLovin ( APP) will report its results for the third-quarter on Wednesday, November 5th, after market close. Wall Street expects the company to post EPS of $2.49 (+99.2% Y/Y), while revenue is ...